Let’s Heal™ is the result of 75 years experience in developing our products to help you test, protect, promote and comfort the wound towards healing.

FIND OUT MORE

INADINE wound dressingINADINE®


INADINE® PVP-I Non-Adherent Dressing consists of a low adherent knitted viscose fabric impregnated with a polyethylene glycol (PEG) base containing 10% Povidone Iodine; equivalent to 1.0% available iodine.

Iodine is a highly effective topical antimicrobial that has been used clinically in the treatment of wounds for more than 170 years1. It has a broad spectrum of antimicrobial activity with efficacy against bacteria, microbacteria, fungi, protozoa and viruses1.

INADINE® Product sizes
Please refer to the relevant country website for correct product codes,
sizes and cartons configurations.

Latest news:
Evaluation of a non-adherent, povidone–iodine dressing in a case series of chronic wounds
Click here for more news & evidence on INADINE®

Disclaimer:
The product information on this page is not intended to be used by health care professionals or users in the United States and may not comply with the regulatory standards of the United States – please click the link above for product information in respect of products used in the United States


© Systagenix Wound Management 2013. Brands marked with ® or ™ are trademarks of Systagenix. All other products referenced herein are acknowledged to be trademarks of their respective owners.


C1675 Nov 2013
PRB C1276

References

References


1. Sibbald, R.G. et al. Iodine Made Easy. Wounds International 2011; 2(2).

2. Langley, S.R.N. INADINE* wound dressings speed healing, reduce patient discomfort and cuts costs by almost 40%. Burns 1989 Vol.15.

3. Vowden, P. and Cooper, R.A . An integrated approach to managing wound infection Position Document: Management of wound infection. European Wound Management Association (EWMA). London: MEP Ltd, 2006.

4. Balmforth, V. INADINE Povidone Iodine non adherent dressing as a treatment for superficial wounds infected with Methicillin resistant Staphylococcus aureus. Case Study, 1996.

5. Gordon, J. Clinical significance of methicillin-sensitive and methicillin resistant Staphylococcus aureus in UK hospitals and the relevance of povidone iodine in their control. Postgrad. Med J. 1993, 69(3):106-116.

6. Han K.H et al. Management of partial skin thickness burn wounds with INADINE® dressings. Burns 1989 Vol.15 (6) 399-402.

7. Campbell, N. and Campbell, D. et al. Evaluation of a non-adherent, povidone–iodine dressing in a case series of chronic wounds. Journal of Wound Care, Vol 22, No 8, August 2013.

8. Hill, K.E. et al. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J Antimicrob Chemother 2010:1195-1206.

9. Witkowski, K. Practice Improvements Related to the Use of Antimicrobial/Antiseptic Products. Poster CAWC 2011.

10. Jeffcoate, W.J. et al. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes. Health Technology Assessment 2009; Vol. 13: No. 54.


C1675 Nov 2013

PRB C1276